Sarissa Capital Management as of Dec. 31, 2015
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 17 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biogen Idec (BIIB) | 18.5 | $95M | 310k | 306.35 | |
| Abbvie (ABBV) | 18.2 | $94M | 1.6M | 59.24 | |
| Ariad Pharmaceuticals | 15.6 | $80M | 13M | 6.25 | |
| Medicines Company | 11.4 | $59M | 1.6M | 37.34 | |
| Quest Diagnostics Incorporated (DGX) | 8.0 | $41M | 575k | 71.14 | |
| Pacira Pharmaceuticals (PCRX) | 8.0 | $41M | 532k | 76.79 | |
| Intra Cellular Therapies (ITCI) | 7.1 | $36M | 675k | 53.79 | |
| Aegerion Pharmaceuticals | 5.1 | $26M | 2.6M | 10.10 | |
| Amgen (AMGN) | 2.8 | $15M | 90k | 162.33 | |
| Esperion Therapeutics (ESPR) | 1.9 | $10M | 448k | 22.26 | |
| Apricus Bioscience | 1.3 | $6.5M | 6.5M | 0.99 | |
| Array BioPharma | 0.6 | $3.0M | 700k | 4.22 | |
| AVEO Pharmaceuticals | 0.6 | $2.9M | 2.3M | 1.26 | |
| Vivus | 0.5 | $2.6M | 2.6M | 1.02 | |
| Biosante Pharmaceuticals (ANIP) | 0.3 | $1.4M | 31k | 45.13 | |
| Repros Therapeutics | 0.2 | $1.2M | 1.0M | 1.21 | |
| Targacept Inc Conv Dtd convertible | 0.1 | $680k | 680k | 1.00 |
